GlobalData reports Ozempic price cut to slow consumer shift toward alternative treatments
The company aims to make FDA approved semaglutide therapies safer and more financially accessible, compared to compounded weight-loss alternatives.
Ozempic
The company aims to make FDA approved semaglutide therapies safer and more financially accessible, compared to compounded weight-loss alternatives.